Brain Prolyl Endopeptidase Expression in Aging, APP Transgenic Mice and Alzheimer’s Disease

Author： Roßner Steffen Schulz Ingo Zeitschel Ulrike Schliebs Reinhard Bigl Volker Demuth Hans-Ulrich

ISSN： 0364-3190

Source： Neurochemical Research, Vol.30, Iss.6-7, 2005-06, pp. : 695-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure and permeability changes of the blood-brain barrier in APP/PS1 mice: an Alzheimer's disease animal model

By Wang Yulin Liu Jing Zhang Zhongmin Wang Xiaoli Zhang Chaodong

Neurochemical Journal, Vol. 5, Iss. 3, 2011-09 ,pp. : 220-222

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Effects of Cerebrolysin™ on neurogenesis in an APP transgenic model of Alzheimer’s disease

By Rockenstein Edward Mante Michael Adame Anthony Crews Leslie Moessler Herbert Masliah Eliezer

Acta Neuropathologica, Vol. 113, Iss. 3, 2007-03 ,pp. : 265-275

Springer Publishing Company

Access to resources Recommend Favorite

Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease

By Schäfer S. Wirths O. Multhaup G. Bayer T. A.

Journal of Neural Transmission, Vol. 114, Iss. 3, 2007-03 ,pp. : 387-394

Springer Publishing Company

Access to resources Recommend Favorite

Valproic Acid Attenuates Neuronal Loss in the Brain of APP/PS1 Double Transgenic Alzheimer's Disease Mice Model

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 261-269

Bentham Science Publishers

Access to resources Recommend Favorite

Nogo Receptor Interacts with Brain APP and A&bgr; to Reduce Pathologic Changes in Alzheimer's Transgenic Mice

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 568-570

Bentham Science Publishers

Access to resources Recommend Favorite